๐ŸŒ EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

16 recruiting trials

for HER2-Expressing Solid Tumors

EGFR/HER2 Dual-Target CAR-NK Cells for Recurrent or Metastatic HNSCC NCT07617805Phase 1, Phase 21 site๐Ÿ“ Shenzhen Beijing Biotech ยท Tests: EGFR/HER2 Dual-Target CAR-NK Cells, Fludarabine, Cyclophosphamide HF158K1 in Patients With HER-2 Expressing Advanced Solid Tumors NCT05861895Phase 12 sites๐Ÿ“ Dallas๐Ÿ“ Guangzhou HighField Biopharmaceuticals Corporation ยท Tests: HF158K1 / 1.4 g lipid dose, HF158K1 / 2.2 g lipid dose, HF158K1 / 2.9 g lipid dose Gene Therapy for HER-Positive Cancer (SENTRY-HER2) NCT07192432Phase 1, Phase 211 sites๐Ÿ“ Los Angeles๐Ÿ“ Denver๐Ÿ“ Jacksonville Vironexis Biotherapeutics Inc. ยท Tests: Dose Level 1, VNX-202, Dose Level 2, VNX-202, Dose Level 3, VNX-202, Dose Level 4, VNX-202 Safety, Pharmacokinetics, Pharmacodynamics and Preliminary Efficacy of MT-304 in Adults With Advanced HER2-Expressing Solid Tumors NCT07334119Phase 17 sites๐Ÿ“ Darlinghurst๐Ÿ“ Randwick๐Ÿ“ Waratah Myeloid Therapeutics ยท Tests: MT-304, MT-304 + Nivolumab Clinical Studies of TQB2930 Injection for the Treatment of Advanced Solid Tumors NCT07512583Phase 1, Phase 23 sites๐Ÿ“ Beijing๐Ÿ“ Harbin๐Ÿ“ Tianjin Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharโ€ฆ ยท Tests: TQB2930 injection+TQB2102 for injection To Evaluate IAH0968 in Combination With CAPEOX in HER2-positive Gastric Cancer NCT06504732Phase 2, Phase 32 sites๐Ÿ“ Harbin๐Ÿ“ Shenyang SUNHO๏ผˆChina๏ผ‰BioPharmaceutical CO., Ltd. ยท Tests: IAH0968, Trastuzumab Injection A Phase โ… /โ…กa Study of HMPL-A251 in Participants With Advanced or Metastatic HER2-expressing Solid Tumors NCT07228247Phase 1, Phase 215 sites๐Ÿ“ Denver๐Ÿ“ Plantation๐Ÿ“ Plantation Hutchmed ยท Tests: HMPL-A251, HMPL-A251 SSGJ-705 Monotherapy and Combination Therapy in Advanced HER2-Expressing Solid Tumors NCT07022002Phase 21 site๐Ÿ“ Hangzhou Shenyang Sunshine Pharmaceutical Co., LTD. ยท Tests: SSGJ-705, PD-1/L1 inhibitor combined with chemotherapy, SSGJ-705 combined with chemotherapy Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors NCT06293898Phase 126 sites๐Ÿ“ Birmingham๐Ÿ“ Duarte๐Ÿ“ Los Angeles SystImmune Inc. ยท Tests: BL-M07D1 A Study of BL-M07D1 in Patients With a Variety of Solid Tumors Including Locally Advanced or Metastatic HER2-positive/Low-expressing Urinary and Gastrointestinal Tumors NCT06031584Phase 1, Phase 21 site๐Ÿ“ Beijing Sichuan Baili Pharmaceutical Co., Ltd. ยท Tests: BL-M07D1 Testing the Safety of the Combination of Anti-Cancer Drugs CX-5461 (Pidnarulex) and Trastuzumab Deruxtecan (T-DXd) for Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Solid Tumors and Breast Cancer NCT07137416Phase 12 sites๐Ÿ“ Boston๐Ÿ“ St Louis National Cancer Institute (NCI) ยท Tests: Biopsy Procedure, Biospecimen Collection, Echocardiography Test, Multigated Acquisition Scan, Pidnarulex A Trial of SHR-A1811 Combined With Other Antitumor Therapies in Advanced Solid Tumors. NCT06015048Phase 1, Phase 215 sites๐Ÿ“ Hefei๐Ÿ“ Beijing๐Ÿ“ Chongqing Jiangsu HengRui Medicine Co., Ltd. ยท Tests: SHR-A1811 combined with Pyrotinib., SHR-A1811 combined with other antitumor therapies Testing the Combination of DS-8201a and Olaparib in HER2-Expressing Cancers With Expansion in Patients With Platinum Resistant Ovarian Cancer NCT04585958Phase 113 sites๐Ÿ“ Phoenix๐Ÿ“ Coral Gables๐Ÿ“ Deerfield Beach National Cancer Institute (NCI) ยท Tests: Biopsy Procedure, Biospecimen Collection, Computed Tomography, Echocardiography Test, Multigated Acquisition Scan SSGJ-705 Plus SSGJ-612 ยฑ Chemotherapy in Advanced HER2-Expressing Solid Tumors NCT07646626Phase 21 site๐Ÿ“ Hangzhou Shenyang Sunshine Pharmaceutical Co., LTD. ยท Tests: SSGJ-705, SSGJ-612, SSGJ-705 combined with chemotherapy A Phase 2 Study of Zanidatamab in Patients With HER2-expressing Tumors NCT06695845Phase 228 sites๐Ÿ“ Prescott๐Ÿ“ Littleton๐Ÿ“ Fort Myers Jazz Pharmaceuticals ยท Tests: Zanidatamab Testing the Combination of the Anticancer Drugs Trastuzumab Deruxtecan (DS-8201a) and Azenosertib (ZN-c3) in Patients With Stomach or Other Solid Tumors NCT06364410Phase 11 site๐Ÿ“ Houston National Cancer Institute (NCI) ยท Tests: Azenosertib, Biopsy Procedure, Biospecimen Collection, Computed Tomography, Echocardiography Test
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy